Related Experiment Video
Updated: Aug 6, 2026

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
Published on: March 7, 2019
Effects of apoE isoforms on beta-amyloid-induced matrix metalloproteinase-9 in rat astrocytes
Shuzhen Guo1, Sophia Wang, Woo Jean Kim
1Department of Neurology, Mass General Hospital, Charlestown, MA, USA.
Abstract:
Matrix metalloproteinase-9 (MMP-9) may play a role in the inflammatory glial response during Alzheimer's disease (AD). Astrocytes can degrade beta-amyloid (Abeta) and extracellular proteolysis via MMP-9 may be involved. Because Apolipoprotein E (APOE) genotype is an important factor for AD, we ask whether various apoE isoforms can influence Abeta-induced MMP-9 responses in primary rat astrocytes. Our data show that apoE4 significantly dampens Abeta-induced MMP-9 levels, possibly by downregulating the Rho-Rho kinase (ROCK) pathway. Reduction of astrocytic MMP-9 by apoE4 may affect Abeta clearance and promote Abeta deposition in AD.
Insights
The Apolipoprotein E4 (APOE4) isoform may hinder Alzheimer's disease (AD) progression by reducing beta-amyloid (Abeta) clearance. This suggests APOE4 dampens the inflammatory response, potentially impacting Abeta deposition in AD.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Matrix metalloproteinase-9 (MMP-9) is implicated in the inflammatory glial response in Alzheimer's disease (AD).
- Astrocytes, a type of glial cell, can degrade beta-amyloid (Abeta), a key protein in AD pathology.
- Extracellular proteolysis mediated by MMP-9 may be involved in Abeta degradation by astrocytes.
Purpose of the Study:
- To investigate the influence of different Apolipoprotein E (APOE) isoforms on Abeta-induced MMP-9 responses in primary rat astrocytes.
- To determine if APOE genotype affects the expression or activity of MMP-9 in astrocytes exposed to Abeta.
Main Methods:
- Primary rat astrocytes were cultured and treated with beta-amyloid (Abeta).
- The expression levels of Matrix metalloproteinase-9 (MMP-9) were measured in response to Abeta exposure.
- The effect of different Apolipoprotein E (APOE) isoforms (including APOE4) on Abeta-induced MMP-9 levels was analyzed.
- The involvement of the Rho-Rho kinase (ROCK) pathway was investigated.
Main Results:
- Apolipoprotein E4 (APOE4) significantly reduced Abeta-induced MMP-9 levels in primary rat astrocytes.
- The dampening effect of APOE4 on MMP-9 was potentially mediated by the downregulation of the Rho-Rho kinase (ROCK) pathway.
- These findings suggest that APOE4 influences the proteolytic activity of astrocytes.
Conclusions:
- APOE4 may impair the clearance of Abeta by astrocytes by reducing MMP-9 activity.
- This reduction in astrocytic MMP-9 could contribute to increased Abeta deposition in Alzheimer's disease.
- The APOE genotype plays a crucial role in modulating the glial response and Abeta metabolism in AD.

